Bayer flags major Phase III results for stroke prevention drug asundexian
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms
Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district
Subscribe To Our Newsletter & Stay Updated